Search
- Apr 26
Gilead's Dan O'Day on 1Q23 Earnings
BiotechTV's exclusive interview with Gilead Sciences' Chairman & CEO Dan O'Day on the company's Q1 2023 earnings day.
- Jan 10
Kite Pharma's Kristi Shaw talks cell therapy at #JPM23
Kite’s Kristi Shaw discusses BCMA, moving CAR-T into earlier lines of treatment, and focusing on improving auto programs.
